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The limited availability of highly selective cathepsin substrates
seriously impairs studies designed to monitor individual cathepsin
activities in biological samples. Among mammalian cysteine
proteases, cathepsin K has a unique preference for a proline resi-
due at P2, the primary determinant of its substrate specificity.
Interestingly, congopain from Trypanosoma congolense also ac-
commodates a proline residue in its S2 subsite. Analysis of a
congopain model showed that amino acids forming its S2 sub-
site are identical with those of cathepsin K, except Leu67 which is
replaced by a tyrosine residue in cathepsin K. Furthermore, amino
acid residues of the congopain S2′ binding pocket, which accepts
a proline residue, are strictly identical with those of cathepsin K.
Abz-HPGGPQ-EDN2ph [where Abz represents o-aminobenzoic
acid and EDN2ph (= EDDnp) represents N-(2,4-dinitrophenyl)-
ethylenediamine], a substrate initially developed for trypanosomal
enzymes, was efficiently cleaved at the Gly–Gly bond by cath-
epsin K (kcat/Km = 426 000 M−1 · s−1). On the other hand, Abz-
HPGGPQ-EDN2ph was resistant to hydrolysis by cathepsins B,
F, H, L, S and V (20 nM enzyme concentration) and the Y67L
(Tyr67 → Leu)/L205A cathepsin K mutant (20 nM), but still acted
as a competitive inhibitor. Taken together, the selectivity of Abz-
HPGGPQ-EDN2ph to cathepsin K primarily depends on the S2
and S2′ subsite specificities of cathepsin K and the ionization
state of histidine at P3. Whereas Abz-HPGGPQ-EDN2ph was
hydrolysed by wild-type mouse fibroblast lysates, its hydrolysis
was completely abolished in the cathepsin K-deficient samples,
indicating that Abz-HPGGPQ-EDN2ph can be used to monitor
selectively cathepsin K activity in physiological fluids and cell
lysates.
Key words: cathepsin, cysteine protease, fluorogenic substrate,
trypanosome.
INTRODUCTION
Mammalian lysosomal papain-like CPs (cysteine proteases) have
been described traditionally as housekeeping enzymes mostly
restricted to non-specific intracellular protein turnover [1]. How-
ever, an increasing number of studies using specific inhibitors and/
or probes as well as protease-deficient mouse models have
demonstrated that these enzymes, including cathepsins B, K, L or
S, also fulfil more specific physiological functions in MHC-II
antigen presentation, in extracellular-matrix turnover, and in
prohormone processing (see [2] for a review). In addition, thiol-
dependent cathepsins are involved in a variety of diseases such
as inflammation, angiogenesis, tumour metastasis, osteoporosis
and rheumatoid arthritis, and represent promising drug targets
of clinical interest [3]. However, a major drawback is the lack of
highly specific and selective substrates capable of monitoring their
individual enzymic activities.
Among mammalian CPs, cathepsin K exhibits the highest
capability to degrade components of the extracellular matrix.
Although cathepsin K shows a restricted pattern of tissue ex-
pression and is predominantly expressed in osteoclasts and multi-
nucleated giant cells [4], it is also found in lung epithelial cells,
in cancer prostate cells, in differentiated macrophages or in the
serum of Gaucher patients [5–8]. The emerging role of cathepsin
K in bone remodelling led us to believe that the development of
Abbreviations used: Abz, o-aminobenzoic acid; AMC, 7-amino-4-methyl-coumarin; cat K−/−, cathepsin K knockout; CP, cysteine protease; C-4S,
chondroitin-4 sulphate; DTT, DL-dithiothreitol; E-64, L-3-carboxy-trans-2,3-epoxypropionyl-leucylamido-(4-guanidino)butane; EDN2ph (=EDDnp), N-(2,4-
dinitrophenyl)ethylenediamine; IQF, intramolecularly quenched fluorescence; KO, knockout; RP, reversed phase; TFA, trifluoroacetic acid; WT, wild-type;
Z, benzyloxycarbonyl.
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peptidomimetics as cathepsin K inhibitors would provide new
therapeutics to treat osteoporosis [4,9,10]. Despite the recent
development of potent drug candidates [2,11], a better knowledge
of the physiological role of cathepsin K and its substrate specificity
remains of major interest for supporting the design of more
efficient cathepsin K inhibitors. The individual monitoring of
cathepsin K activity in biological fluids or in tissue extracts
is seriously hampered by the lack of a selective substrate. Z-
GPR-AMC (where Z stands for benzyloxycarbonyl and AMC
for 7-amino-4-methyl-coumarin) shows some selectivity for cath-
epsin K, but it is also well hydrolysed by cathepsin B, granzyme
A, trypsin, thrombin and tryptase [4,12,13]. Analyses of cleavage
sites of cathepsin K in type I and II collagens [14,15], as well
as profiling of its substrate specificity using positional scanning
(P1–P4) tetrapeptide libraries [16], confirmed that cathepsin
K exhibits a unique preference for a proline residue at P2
among mammalian cathepsins, which has been attributed to
the presence of Tyr67 and Leu205 in the S2 binding pocket, the
major determinant for substrate specificity. Interestingly, CPs
from Trypanosoma cruzi (cruzipain) and T. congolense (congo-
pain), which play a key role in the pathogenicity of the para-
sites, also accommodate a proline residue in S2 and a proline
residue in S2′ [17,18]. We have recently designed an IQF
(intramolecularly quenched fluorescence) substrate, namely Abz-
HPGGPQ-EDN2ph [where Abz represents o-aminobenzoic acid
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and EDN2ph (= EDDnp) represents N-(2,4-dinitrophenyl)ethyl-
enediamine], which is specifically hydrolysed by the two try-
panosomal CPs at the Gly–Gly bond [19].
On the basis of these results and supported by structural analysis
of the active sites of congopain and cathepsin K, the aim of
the present study was to determine if a fluorogenic substrate,
originally designed for trypanosomal CPs, might be a selective
substrate for human cathepsin K.
EXPERIMENTAL
Materials
DTT (DL-dithiothreitol), E-64 [L-3-carboxy-trans-2,3-epoxypro-
pionyl-leucylamido-(4-guanidino)butane] and C-4S (chondroitin-
4 sulphate) were obtained from Sigma–Aldrich (St. Quentin le
Fallavier, France). Z-FR-AMC and Arg-AMC were purchased
from Bachem (Weil am Rhein, Germany). All other reagents were
of analytical grade.
Enzymes
Human cathepsins B, L and S were supplied by Calbiochem
(VWR International, Pessac, France). WT (wild-type) human
cathepsin K and the Y67L (Tyr67 → Leu)/L205A cathepsin K
mutant were expressed in Pichia pastoris as described elsewhere
[16]. Recombinant human cathepsins F and V were produced as
reported previously [20,21]. Cathepsin H was prepared from rat
liver [22]. Congopain (CP2 type) was purified from T. congolense
lysates [23]. The activation buffers for enzyme assays were: 0.1 M
phosphate buffer (pH 6.0), containing 2 mM DTT and 2 mM
EDTA for cathepsins B, H, L, K and S and the Y67L/L205A
mutant; 0.1 M acetate buffer (pH 5.5), containing 2.5 mM DTT
and 2.5 mM EDTA for cathepsins V and F; and 0.1 M phosphate
buffer (pH 6.0), containing 6 mM DTT and 2 mM EDTA for
congopain. The molarity of the proteases was determined using
E-64 as the active-site titrant [24].
Structural analysis of cathepsin K and congopain
A homology-based model of the catalytic domain of congopain
(GenBank® accession no. L25130) was developed previously,
using papain, actinidin, papaya protease ω and cruzain as mol-
ecular templates [25]. The three-dimensional structure of human
cathepsin K corresponded to a pyrrolidinone inhibitor–cathepsin
K complex (accession number 1AU3). Both structures were
superimposed using the Homology program (INSIGHT II
software, Molecular Simulations, San Diego, CA, U.S.A.), as
described previously [16]. All calculations were performed on a
Silicon Graphics O2 workstation.
Peptide synthesis
Abz-HPGGPQ-EDN2ph, a substrate with resonance energy
transfer properties due to a donor group (Abz) and a fluorescence
quencher group (EDN2ph), was synthesized by fluoren-9-
ylmethoxycarbonyl solid-phase peptide synthesis procedure as
described by Serveau et al. [19]. A stock solution of 2 mM Abz-
HPGGPQ-EDN2ph, dissolved in dimethylformamide, was stored
at − 80 ◦C until use.
Kinetic measurements
The enzymic activity of 1 nM cathepsin K was followed by
monitoring the hydrolysis of Abz-HPGGPQ-EDN2ph at an ex-
citation wavelength of 320 nm and an emission wavelength of
420 nm (Kontron SFM 25 spectrofluorimeter). Fluorescence
calibration was performed as reported previously [17]. Experi-
ments were performed in triplicate at 30 ◦C in the presence or
absence of 0.15% (w/v) C-4S. Kinetic results were determined
by running the Enzfitter software (Biosoft, Cambridge, U.K.) and
were reported as means +− S.D.
Second-order rate constants (kcat/Km) were first measured under
pseudo-first-order conditions, i.e. using a substrate concentration
far below the Km. Michaelis constant and catalytic constant values
were obtained graphically from a Hanes linear plot using various
concentrations of substrate (0.1–10 µM), and the accuracy of Km
and kcat values was confirmed by non-linear regression analysis
(substrate concentration: 0.2–6 µM) [26]. The same procedure
was applied for 1 nM congopain. Resistance of Abz-HPGGPQ-
EDN2ph to hydrolysis by cathepsins B, F, H, L, S and V and by
Y67L/L205A cathepsin K mutant was measured using a 20 nM
enzyme concentration.
Determination of inhibitory constant K i
Cathepsin L (5 nM) was incubated with Abz-HPGGPQ-EDN2ph
(1–100 µM) in the activating buffer at 25 ◦C for 10 min, in a final
volume of 300 µl. The residual enzymic activity was recorded in
the presence of 3–10 µM Z-FR-AMC at an excitation wavelength
of 350 nm and an emission wavelength of 460 nm. The K i value
was calculated by plotting 1/v against inhibitor concentration [I]
(Dixon plot). The competitive inhibition of cathepsins B and S
and the Y67L/L205A mutant (5 nM each) by Abz-HPGGPQ-
EDN2ph was measured using the same method. In addition,
Michaelis constants for 2 nM cathepsin L, 2 nM cathepsin B and
3 nM cathepsin S were also deduced from non-linear regression
analysis, using Z-FR-AMC as a substrate (0.5–50 µM) [26].
Reversed phase (RP)-HPLC analysis
Cathepsin K (10 nM) was incubated with 100 µM Abz-
HPGGPQ-EDN2ph in its activation buffer at 30 ◦C (final volume:
30 µl) for 1 h, before adding 100 µl of ethanol. After removal
of the precipitate, the supernatant containing the native peptide
and/or its proteolytic fragments was evaporated, and re-dissolved
in 0.1%TFA (trifluoroacetic acid). An aliquot of each sample was
fractionated by RP-HPLC on a C18 OD-300 column (Brownlee
ABI, Weiterstadt, Germany), using a 30 min linear gradient (0–
60%) of acetonitrile in 0.1% TFA at a flow rate of 0.3 ml/
min. Proteolysis products were identified by comparison with
intact Abz-HPGGPQ-EDN2ph, and the elution profiles were
analysed by running the ChromQuest chromatography work-
station (ThermoFinnigan, Les Ulis, France). Cleavage sites were
located by N-terminal sequencing (Procise sequencer, Applied
Biosystems). The same procedure was repeated for cathepsins B,
L, S and Y67L/L205A (10 nM).
pH–activity profiles
The pH–activity profiles of human cathepsin K and congopain
were determined at 0.3 µM substrate concentration (S < Km,
where the initial rate vo is directly proportional to the kcat/Km
value). Measurements were performed using 100 mM NaH2PO4/
50 mM citric acid buffers (pH range 3.0–8.0), containing 2 mM
DTT and 2 mM EDTA for cathepsin K and 10 mM DTT and
2 mM EDTA for congopain.
Activity assays of cathepsin K on cultured fibroblasts
Cathepsin K knockout (cat K−/−) mice (C57BL/6J background)
were generated by targeted disruption of the cathepsin K gene
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Figure 1 Substrate binding clefts of cathepsin K and congopain
A three-dimensional model of the catalytic domain of congopain [25] was superimposed to the X-ray structure of pyrrolidinone-bound cathepsin K (accession number 1AU3). Only the side chains of
residues lining the S2 and S2′ pockets (Connolly surface) are shown (cathepsin K, dark; congopain, light grey). The covalently bound inhibitor (stick representation; dark grey) is shown interacting
with the binding sites S3-S3′.
[27] and were kindly provided by Dr Paul Saftig (University
of Kiel, Kiel, Germany). Skin specimens (5 mm × 5 mm) were
collected from WT and cat K−/− mice. After treatment for 3 h at
room temperature (22 ◦C) with Dispase II (Roche Diagnostics,
Mannheim, Germany) and in the presence of 1% penicillin
G, amphotericin B and streptomycin B (Cellgro, Mediatech,
Herdon, VA, U.S.A.), samples were placed at 37 ◦C on 25 cm2
culture flasks in Dulbecco’s modified Eagle’s medium (Gibco
BRL, Gaithersburg, MD, U.S.A.), containing 1% penicillin G,
amphotericin B and streptomycin B and supplemented with
20% (v/v) foetal calf serum (Gibco BRL). Cells were grown
at 37 ◦C in an atmosphere containing 5% CO2. When cells
reached confluence, they were detached with 0.25% trypsin and
divided in the ratio 1:3. The amount of foetal calf serum was
then decreased to 10%. Cell monolayers were washed twice
with PBS, trypsinized, resuspended in PBS and washed again
twice before centrifugation at 800 g for 10 min at 4 ◦C. Finally,
cell lysates were prepared in 100 mM sodium acetate buffer
(pH 5.5), containing 2.5 mM DTT, 2.5 mM EDTA, 10 µM PMSF
and 10 µM pepstatin. After centrifugation at 13000 g for 10 min
at 4 ◦C, protein concentrations in the supernatants of WT and
knockout (KO) cells were determined using the Bradford kit (Bio-
Rad Laboratories, Hercules, CA, U.S.A.).
Extracted proteins (1 µg) were resolved by SDS/PAGE
(10% gel) and transferred on to PVDF membranes (Millipore,
Bedford, MA, U.S.A.). Non-specific binding was blocked by 2 h
incubation in PBS/0.1% Tween 20, containing 5% (v/v) non-
fat dried milk. The membranes were incubated overnight with a
rabbit polyclonal antibody directed against mouse cathepsin K
(1:1000 in PBS/0.1% Tween 20) as described previously [4].
The membranes were then incubated with a goat anti-rabbit
IgG(H + L)–peroxidase conjugate (Southern Biotechnology
Associates, Birmingham, AL, U.S.A.) for 1 h, before detection
using the chemiluminescent ECL® kit (Amersham Biosciences,
Little Chalfont, Bucks., U.K.).
Residual enzymic activity of lysate supernatants (10 µg of
protein/assay) was monitored using 5 µM Z-FR-AMC as the
substrate at 25 ◦C in 100 mM sodium acetate buffer (pH 5.5),
containing 2.5 mM DTT and 2.5 mM EDTA. Enzymic activities
towards 5.6 µM Abz-HPGGPQ-EDN2ph were determined under
the same conditions, except that 50 µg of protein/assay was used.
RESULTS AND DISCUSSION
Comparative structural analysis of cathepsin K and congopain
The substrate specificity of papain-like CPs primarily depends on
P2–S2 interactions. Most of them exhibit a marked preference for
bulky hydrophobic or aromatic residues at P2, whereas cathepsin
K preferentially accommodates a proline residue at its S2 binding
site [16]. Similarly, we have reported previously that both cruzain,
the major CP of T. cruzi (the etiological agent of Chagas disease in
South America), and congopain, its homologue in T. congolense,
accept a proline residue in the S2 pocket [19]. The catalytic
domain of congopain shares more than 65% similarity in the
sequence with cathepsin K and has structural features similar
to that of cathepsin K. Amino acids constituting the congopain
S2 binding pocket are identical with those of cathepsin K, with
the noticeable exception of Leu67, which is replaced by a tyrosine
residue in cathepsin K (Figure 1). In addition, constitutive residues
c© 2003 Biochemical Society
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Table 1 Kinetic parameters for the hydrolysis of Abz-HPGGPQ-EDN2ph and
Z-GPR-AMC
Experiments were performed as described in the Experimental section. K m and k cat values for
Abz-HPGGPQ-EDN2ph hydrolysis were determined by non-linear regression analysis. n.d., not
determined.
k cat/K m (M−1 · s−1)
Enzyme Abz-HPGGPQ-EDN2ph Z-GPR-AMC*
Cathepsin K 426 000 117 600
K m = 1.2 +− 0.2 µM K m = 68 +− 21 µM
k cat = 0.5 +− 0.03 s−1 k cat = 8 +− 1.8 s−1
285 000 +− 43 000†
Cathepsin K + C-4S‡ 294 000 +− 2000† n.d.
Y67L/L205A nsh§ 122‖
Cathepsin B nsh§ 9490
Cathepsin L nsh§ 370
Cathepsin S nsh§ 34
Cathepsins F, H and V nsh§ n.d.
Congopain 110 000 +− 6000† n.d.
* From [4].
† Determined under pseudo-first-order conditions.
‡ 0.15 % (w/v) C-4S [28].
§ nsh, no significant hydrolysis (enzyme concentration 20 nM).
‖ From [16].
of the putative S2′ subsite of congopain (namely Gln19, Gly20,
Gln21, Cys22, Gly23 and Ser24) are strictly identical with those
of cathepsin K (Figure 1). The active sites of both enzymes
display a very similar structural framework, with the exception
of Gln21 in congopain whose side chain shifts after exposure to
solvent. However, this different orientation may not be significant
and may have been induced by additional interactions between
cathepsin K and its covalently bound peptidyl pyrrolidinone
inhibitor (accession number 1AU3).
Specific hydrolysis of Abz-HPGGPQ-EDN2ph by cathepsin K
On the basis of the similar structural properties of cathepsin K and
congopain (see above) and previous substrate specificity studies
[17–19], the ability of cathepsin K to cleave Abz-HPGGPQ-
EDN2ph has been determined. Km and kcat values were determined
from Hanes plots and non-linear regression analysis, whereas
the specificity constant (kcat/Km) was deduced from individual
Km and kcat values and from analysis under pseudo-first-order
conditions. Analysis of the second-order rate constant showed
that cathepsin K accommodated well Abz-HPGGPQ-EDN2ph in
its active site (Table 1) and hydrolysed it approx. 4-fold better
than Z-GPR-AMC (kcat/Km = 118750 M−1 · s−1). This was mostly
due to a dramatic improvement of affinity (1.2 versus 68 µM).
Cleavage occurred at the Gly–Gly bond, similar to that observed
with congopain and cruzipain [19]. Michaelis constants are very
similar for cathepsin K and congopain. Whereas C-4S, a major
component of extracellular matrixes, enhances the collagenolytic
activity of cathepsin K and increases its stability at neutral pH
[28,29], we found that the presence of C-4S did not modify
the specificity constant for Abz-HPGGPQ-EDN2ph (Table 1), as
reported already for other small synthetic substrates [28]. In the
presence of 20-fold higher amounts of cathepsins B, F, H, L, S and
V (20 nM), no detectable release of fluorescence was observed,
indicating that Abz-HPGGPQ-EDN2ph was not susceptible to
hydrolysis by these enzymes. Furthermore, no cleavage products
were detected by RP-HPLC, confirming the resistance of Abz-
HPGGPQ-EDN2ph to proteolysis. The serine proteases cathepsin
G, chymotrypsin and leucocyte elastase were also unable to
cleave Abz-HPGGPQ-EDN2ph, despite their known capability to
accommodate a proline residue at P2 [30]. Interestingly, the Y67L/
L205A cathepsin K mutant was also unable to hydrolyse Abz-
HPGGPQ-EDN2ph. The fact that this mutant excludes the
binding of a proline residue at P2 [16] supports the idea that
interactions between cathepsin K and Abz-HPGGPQ-EDN2ph
critically depend on P2 proline–S2 interactions. On the other
hand, cathepsin L, as well as WT and Y67L/L205A cathepsin K
[16], accommodates a histidine residue in their S3 binding site,
suggesting that this residue at P3 does not play a key role in
terms of selectivity for Abz-HPGGPQ-EDN2ph hydrolysis. The
presence of a glycine residue at P1 of Abz-HPGGPQ-EDN2ph
confirms that the nature of the amino acids in adjacent positions
could have an influence on the specificity [19,31]. Interestingly,
the IQF substrate displayed striking differences with peptidyl
coumarylamide substrates. No cleavage at the Gln-EDN2ph bond
was observed, although glycine at P1, proline at P2 and glycine at
P3 were reported as favoured residues for cathepsin K [16]. The
resistance to cleavage might rely on the influence of the chemical
nature of the leaving group [32] or, alternatively, EDN2ph
might not fit into the P1′ position. Nevertheless, the present
finding emphasizes the important contribution of primed subsites,
particularly the S2′ subsite, to define cathepsin K specificity in
addition to the primary role of the S2 subsite. The presence of
amino acids in the prime position may have synergistic effects
of binding at different subsites [31] and affects the specificity
on the non-prime side of the scissile bond [16]. Subsequently,
results confirm that IQF substrates are more relevant to investigate
the substrate specificities of endoproteases and that human
cathepsin K exhibits close similarity in substrate specificity
for trypanosomal congopain, including a unique preference for
proline residues at both P2 and P2′ among mammalian CPs.
Competitive inhibition by Abz-HPGGPQ-EDN2ph
Owing to the presence of a histidine residue with a theoretical
pK value close to that of the experimental pH, the influence of
the ionization state of the P3 residue on enzymic activity has
been studied. The bell-shaped pH–activity profiles of cathepsin
K for the hydrolysis of Z-FR-AMC (used as reference) and
Abz-HPGGPQ-EDN2ph showed two different trends (Figure 2).
Whereas cathepsin K cleaved the non-ionizable Z-FR-AMC
substrate over a broad pH range 4.0–8.0, Abz-HPGGPQ-EDN2ph
hydrolysis occurred over a narrow pH range (approx. pH 5.5–7.0),
with a maximal efficiency at pH 6.0. Compared with congopain
(maximal activity at pH 5.0), Abz-HPGGPQ-EDN2ph hydrolysis
by cathepsin K shifted to a less acidic pH (pH = 1), suggesting
that the histidine residue at P3 might be deprotonated (imidazole
form) to allow cleavage. Hydrolysis of Z-FR-AMC by human
cathepsins L, B and S and the Y67L/L205A mutant was decreased
in the presence of increasing amounts of Abz-HPGGPQ-EDN2ph.
Abz-HPGGPQ-EDN2ph inhibited cathepsins B, L and S and the
Y67L/L205A mutant with K i values of 11.3 +− 0.9, 2.1 +− 0.2,
0.8 +− 0.2 and 3.6 +− 2.0 µM respectively. These K i values were
very similar to the Km value reported for cathepsin K (1.2 µM),
except for cathepsin B, which is by one order of magnitude less
efficiently inhibited. Lack of cleavage by cathepsins B, L or S
(as shown by RP-HPLC analysis; results not shown) indicates
that Abz-HPGGPQ-EDN2ph bound to their active site, leading
to a stable Michaelis complex, but the kcat value was impaired.
Similarly, it has been reported that the presence of histidine at P3
dramatically decreased the kcat value for papain [33]. In summary,
the results suggest that the ionization state of the side chain of
histidine at P3 appears to be essential for the catalysis of Abz-
HPGGPQ-EDN2ph. Although the substrate has a similar affinity
c© 2003 Biochemical Society
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Figure 2 pH–activity profiles of congopain and cathepsin K on Abz-
HPGGPQ-EDN2ph and Z-FR-AMC
Relative k cat/K m values for the hydrolysis of Abz-HPGGPQ-EDN2ph () and Z-FR-AMC (H17009)
by cathepsin K and relative k cat/K m values for the hydrolysis of Abz-HPGGPQ-EDN2ph () by
congopain were expressed as normalized rates and plotted against the pH values of the assay.
Figure 3 Immunoblotting of fibroblast lysates using an anti-(cathepsin K)
polyclonal antibody
Extracted proteins (1 µg) of fibroblast lysates from WT and cat K−/− (KO) mice were subjected
to SDS/PAGE (10 % gel) under reducing conditions and transferred on to PVDF membranes.
Bands were revealed by chemiluminescence after incubation with a rabbit polyclonal antibody
directed against mouse cathepsin K (1:1000) [4], as described in the Experimental section.
to mammalian CPs, only cathepsin K hydrolyses Abz-HPGGPQ-
EDN2ph efficiently.
Monitoring of cathepsin K activity in biological samples
The specificity of Abz-HPGGPQ-EDN2ph towards cathepsin
K activity was further investigated by monitoring fluorescence
release. Cell lysates of skin fibroblasts from WT and cat K−/− (KO)
mice were prepared as described in the Experimental section.
Although it is predominantly expressed in osteoclasts, cathepsin
K is also found in other cells, such as lung epithelial cells, activated
macrophages or fibroblasts (see [2] for a review). Western-
blot analysis showed the presence of two bands in normal skin
fibroblasts (Figure 3), which corresponded to procathepsin K and
to its mature processed form. By contrast, no immunoreactivity
was detected in fibroblasts from cat K−/− mice. Supernatants
of WT and cat K−/− cell extracts were further analysed for
their ability to cleave Abz-HPGGPQ-EDN2ph and Z-FR-AMC.
Both WT and cat K−/− supernatants (10 µg of protein/assay)
hydrolysed Z-FR-AMC. Proteolytic activity was slightly higher
Figure 4 Selective hydrolysis of Abz-HPGGPQ-EDN2ph by cathepsin K from
skin fibroblasts
Fibroblast lysates from WT and cat K−/− (KO) mice were prepared as described in the
Experimental section. The protein concentration of cell extract supernatants was determined
using the Bradford kit, and their CP activity (10 µg of total protein/assay) was recorded with
5 µM Z-FR-AMC (5 µM; open bar) at 25 ◦C in 100 mM sodium acetate buffer (pH 5.5),
containing 2.5 mM DTT and 2.5 mM EDTA. Monitoring of Abz-HPGGPQ-EDN2ph hydrolysis
(5.6 µM; black bar) was performed using 50 µg of total protein/assay. Substrate hydrolysis
(fluorescence release) by fibroblast lysates from WT and cat K−/− mice were normalized.
in WT than in cat K−/− samples and was fully abolished by
the addition of E-64, indicating that hydrolysis of Z-FR-AMC
related specifically to CPs. By contrast, fibroblast lysates from
WT mice, but not from cat K−/− (KO) mice, cleaved Abz-
HPGGPQ-EDN2ph (Figure 4). Assuming that Abz-HPGGPQ-
EDN2ph is cleaved similarly by human and mouse cathepsin
K, these results confirm unambiguously that Abz-HPGGPQ-
EDN2ph can be used to monitor selectively cathepsin K activity
in biological samples. Preliminary studies support the idea that
Abz-HPGGPQ-EDN2ph hydrolysis by broncho-alveolar fluids
from patients suffering from inflammatory disorders depends on
their cathepsin K concentration (F. Lecaille and G. Lalmanach,
unpublished work). In conclusion, Abz-HPGGPQ-EDN2ph may
be adequate to probe the presence of cathepsin K activity and to
measure directly and selectively its concentration in physiological
fluids and/or soluble fractions of tissue/cell lysates, such as
osteoclasts, bronchial epithelial cells or cancer prostate cell lines.
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